semaglutide tirzepatide retatrutide The GLP-1 family, explained for researchers: Semaglutide, Tirzepatide, — what they are and the receptor research context. Note: Retatrutide is investigational (Phase 3). No weight-loss or human-effect claims here — just Everyone is talking about GLPs.

GLP-1 medications and the associated weight loss can lead to loss of lean muscle, which reduces strength and endurance

Meanwhile, non-peptide alternatives are also making progress

The glucagon receptor component is significant in research because glucagon drives energy expenditure and hepatic fat metabolism through mechanisms distinct from both GLP-1 and GIP pathways

doi: 10.2337/dc20-2151

LA Times Studios may earn commission from purchases made through our links

This may include a review of your medical history as well as any medications you are currently taking, all to ensure your weight loss program is tailored to your needs